Autonomix Medical (AMIX) Cash from Financing Activities (2023 - 2025)

Autonomix Medical (AMIX) has 3 years of Cash from Financing Activities data on file, last reported at $5.4 million in Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at $5.4 million, down 39.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $19.0 million (down 18.77% YoY), and the FY2025 annual result was $8.8 million, down 38.93% from the prior year.
• Cash from Financing Activities improved to $5.4 million in Q4 2025 per AMIX's latest filing, from $2.7 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $14.4 million in Q1 2024 and troughed at $350000.0 in Q3 2023.
• A 3-year average of $4.8 million and a median of $2.7 million in 2023 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 2034.81% in 2024, then sank 39.46% in 2025.
• A 3-year view of Cash from Financing Activities shows it stood at $1.6 million in 2023, then jumped by 445.53% to $9.0 million in 2024, then slumped by 39.46% to $5.4 million in 2025.
• Business Quant data shows AMIX's Cash from Financing Activities at $5.4 million in Q4 2025, $2.7 million in Q3 2025, and $2.1 million in Q2 2025.